GFAP and amyotrophic lateral sclerosis: Taken together, these data, in agreement with previous reports in smaller ALS cohorts [18,19], suggest that plasma GFAP elevation in ALS also reflects the astrocytic activation secondary to neurodegeneration at sites unrelated to motor neurons.